Founded in 2016, the company has received a $16.00M Venture Round investment as of 20 September 2023. Their cutting-edge technologies, including novel sample preparation methods and machine learning algorithms, enable ultra-high enrichment of pathogen DNA for rapid sequencing directly from clinical samples. Day Zero's fast, accurate, and comprehensive diagnostics not only improve patient outcomes but also result in substantial cost savings in healthcare. With a focus on biotechnology and healthcare, the United States-based company is addressing a critical unmet need in the medical field.
Day Zero Diagnostics, Inc
The future of infectious disease diagnostics starts at Day Zero.
Founded 2016
Boston, United States
64 employees
Total: $63.00M
Biotechnology, Health Care +1
Boston, United States
64 employees
Total: $63.00M
Biotechnology, Health Care +1
General Information
Company Name
Day Zero Diagnostics, Inc
Founded Year
2016
Location
Boston, United States
Boston, United States
Employees
64
Industries
Biotechnology, Health Care, Medical Devices
Social
BounceWatch is an independent company data service, not affiliated with Day Zero Diagnostics, Inc. To contact Day Zero Diagnostics, Inc, visit dayzerodiagnostics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Day Zero Diagnostics, Inc compare?
A PDF of Day Zero Diagnostics, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Day Zero Diagnostics, Inc soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Day Zero Diagnostics, Inc on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Day Zero Diagnostics, Inc
Business keywords: infectious disease diagnostics, whole-genome sequencing, in-vitro diagnostics, clinical data analysis, machine learning algorithms, pathogen DNA enrichment, antibiotic resistance profiling, sepsis diagnostics, clinical sample preparation, real-time sequencing, drug efficacy profiling, biomedical innovation, precision medicine, healthcare cost savings
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Early VC | $16.00M | - |
|
01 Sep 2023 |
| Grant | $8.20M | 1 |
|
01 Oct 2022 |
| Early VC | $21.00M | 5 |
|
01 Feb 2022 |
| Round | Undisclosed | - |
|
01 Dec 2020 |
| Grant | $6.20M | 1 |
|
01 May 2020 |
| Round | Undisclosed | - |
|
01 Jul 2019 |
| Series A | $8.60M | 1 |
|
01 Jan 2019 |
| Seed | Undisclosed | 1 |
|
01 Jun 2018 |
| Grant | Undisclosed | 2 |
|
01 Nov 2017 |
| Seed | $3.00M | 2 |
|
01 Aug 2017 |
Day Zero Diagnostics, Inc Alternatives & Competitors
View All Alternatives
Day Zero Diagnostics, Inc vs
Selux Diagnostics, Inc
United States
Precision diagnostics for infectious disease.
Series D
95 employees
Biotechnology, Health Care
Day Zero Diagnostics, Inc vs
Pattern Bioscience
United States
Our mission is simple: We will improve the world's most important health decisions.
Series C
76 employees
Biotechnology, Health Care
Day Zero Diagnostics, Inc vs
Clear Labs
United States
Provider of fully automated next generation sequencing platforms, software and robotics for turnkey...
Series D
86 employees
AI, Biotechnology
FAQ About Day Zero Diagnostics, Inc
The future of infectious disease diagnostics starts at Day Zero.
Day Zero Diagnostics, Inc was founded in 2016.
Day Zero Diagnostics, Inc is headquartered in Boston, United States.
Day Zero Diagnostics, Inc operates in Biotechnology, Health Care and Medical Devices. Its work centres on infectious disease diagnostics, whole-genome sequencing, in-vitro diagnostics and clinical data analysis.
Day Zero Diagnostics, Inc has approximately 64 employees.
Day Zero Diagnostics, Inc has completed 12 funding rounds, raising a total of $63.00M.
Top alternatives and competitors to Day Zero Diagnostics, Inc include Selux Diagnostics, Inc, Pattern Bioscience, Clear Labs, Congenica, 23Strands. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Day Zero Diagnostics, Inc and Selux Diagnostics, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Day Zero Diagnostics, Inc, https://bouncewatch.com/company/day-zero-diagnostics, updated 9 June 2026. When citing, please name BounceWatch and link this page.
